Feedback / Questions
fianlimab (REGN3767) - Regeneron
Libtayo (cemiplimab-rwlc) - Regeneron
Fianlimab + Libtayo: Launch for melanoma in 2026
(Regeneron Pharmaceuticals, 43rd Annual J.P. Morgan Healthcare Conference)
Jan 13, 2025
Launch
•
Melanoma • Oncology
https://investor.regeneron.com/static-files/f5556fde-092a-4792-ae53-161550abd551
Jan 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious